about
Development of Decision Support Formulas for the Prediction of Bladder Outlet Obstruction and Prostatic Surgery in Patients With Lower Urinary Tract Symptom/Benign Prostatic Hyperplasia: Part I, Development of the Formula and its Internal ValidationUrinary Bladder Dysfunction in Transgenic Sickle Cell Disease MiceAssociation of lower urinary tract syndrome with peripheral arterial occlusive disease.The NLRP3 Inflammasome Mediates Inflammation Produced by Bladder Outlet Obstruction.The link between vascular dysfunction, bladder ischemia, and aging bladder dysfunction.Pharmacological treatment of chronic pelvic ischemia.Lower urinary tract symptoms, benign prostatic hyperplasia/benign prostatic enlargement and erectile dysfunction: are these conditions related to vascular dysfunction?Chronic bladder ischemia and oxidative stress: new pharmacotherapeutic targets for lower urinary tract symptoms.A synopsis of drugs currently in preclinical and early clinical development for the treatment of benign prostatic hyperplasia.Detrusor Underactivity: The Current Concept of the Pathophysiology.OnabotulinumtoxinA Treatment for Overactive Bladder in the Elderly: Practical Points and Future Prospects.Detrusor underactivity and the underactive bladder: Symptoms, function, cause-what do we mean? ICI-RS think tank 2014.Inflammasomes in the urinary tract: a disease-based review.The influence of altitude hypoxia on uroflowmetry parameters in women.Metabolic Stress-Induced Activation of AMPK and Inhibition of Constitutive Phosphoproteins Controlling Smooth Muscle Contraction: Evidence for Smooth Muscle Fatigue?Diminished long-term recovery of peak flow rate (PFR) after robotic prostatectomy in men with baseline PFR <10 mL/s and incidental association with high-risk prostate cancer.Synthetic nickel-containing superoxide dismutase attenuates para-phenylenediamine-induced bladder dysfunction in rats.Increased expression of neuregulin 1 in the urothelium of rat bladder with partial bladder outlet obstruction.Tadalafil, a phosphodiesterase type 5 inhibitor, improves bladder blood supply and restores the initial phase of lower urinary tract dysfunction in diabetic rats.Clinical guidelines for male lower urinary tract symptoms and benign prostatic hyperplasia.Amniotic fluid stem cells ameliorate bladder dysfunction induced by chronic bladder ischemia in rat.Atherosclerosis as a predictor of delayed recovery from lower urinary tract dysfunction after robot-assisted laparoscopic radical prostatectomy.Favorable Outcome of Conservative Management of Extensive Bladder Ischemia Complicating Prostatic Artery Embolization.Is overactive bladder microvasculature disease a component of systemic atheroscleorosis?Association between coronary artery disease severity and overactive bladder in geriatric patients.The Emerging Role of Inflammasomes as Central Mediators in Inflammatory Bladder Pathology.Urodynamic characteristics of detrusor underactivity in women with voiding dysfunction.
P2860
Q33662499-E9FA1ACA-B846-4F7B-8145-88017D76B29DQ35737367-FFF75788-845E-47DC-B468-A6549AC6792EQ36310565-3D8E0022-747E-42B9-B362-5B469A176104Q36909423-EE8D2A7E-108F-4407-9A88-134853ABDBC2Q37514602-C0433D6C-1C8B-4EB0-806F-08F138AEA830Q37730832-939B20A1-9A63-463A-A7DB-C2D9A78441E6Q38220350-D5382BC3-1C52-4A56-BAF0-3B740941D612Q38262087-4E14F820-9AEB-4430-8718-B46B094DCB14Q38485721-376CDB49-E4AC-4377-8BA7-54485CAAEFB5Q38668419-273FB3AB-91E3-4E05-81EC-56BCC429B258Q38669033-B953AC91-6697-4C56-8C8A-5F0EA8356CC4Q38731408-52040193-78CF-489E-8CCB-DD700C4AF502Q38832656-507F66D1-4638-4C58-8E13-433F3BA3D591Q39644071-8E456925-F28B-4C45-8369-9E872909CACAQ41699698-D036275A-5930-478B-85CD-1A863565D885Q46629812-B344998F-35E3-4768-8645-962E25E436CFQ47115356-525A5734-986B-4E63-A991-B8F8A5DE9429Q47139627-B4E969EE-D42F-4736-B743-818D8133EB52Q47675135-436FA10B-A013-41D1-9361-9C3B05151E86Q47704193-6D7E15D2-1295-409E-A0C2-855271B4D761Q47733819-5A0CEBC1-2C27-490C-82C6-B86714BF7D88Q47982936-E08DB913-9F96-4444-B6FD-DF76FF159BB2Q48204745-8B334A1B-3E49-434F-923D-0C8473039638Q48300293-CAD686E4-1F47-4CEE-8303-70E514E416CAQ50070001-0016A489-BFD8-473D-AB4A-19573027B88AQ52723450-55DFBC6F-8C48-4BC8-8555-F8535045FCE4Q55490782-429156D5-0B2E-4B8F-B9D6-64E0100AB472
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Functional consequences of chronic bladder ischemia.
@en
type
label
Functional consequences of chronic bladder ischemia.
@en
prefLabel
Functional consequences of chronic bladder ischemia.
@en
P2093
P2860
P356
P1476
Functional consequences of chronic bladder ischemia.
@en
P2093
Karl-Erik Andersson
Masanori Nomiya
Osamu Yamaguchi
P2860
P356
10.1002/NAU.22517
P577
2013-11-30T00:00:00Z